ArticlePharmacoEconomics2024

Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?

Anna Kenseth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.